Obesity Clinical Trial
Official title:
The Big Breakfast Study: Chrono-nutrition Influence on Energy Expenditure and Body Weight
Verified date | April 2020 |
Source | University of Aberdeen |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This weight loss study will investigate the impact of calorie distribution across a day
(large breakfast meals and smaller evening meals versus small breakfast meals and large
evening meals) on body weight, and physiological and behavioral mechanisms regulating energy
balance.
Participants will undergo 2 x 4 week energy restriction protocols in a randomized cross over
design; big breakfast (45% of calories in the morning meal, 20% at dinner) and big dinner
(45% of calories in the evening meal, 20% at breakfast). We predict that timing of eating
will influence energy balance, because morning energy expenditure is amplified in comparison
to the evening. This study will allow us to assess whether the increased energy expenditure
in the morning is linked to natural biological circadian rhythm or behavioral adaptions.
Status | Completed |
Enrollment | 31 |
Est. completion date | February 28, 2020 |
Est. primary completion date | February 28, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 75 Years |
Eligibility |
Inclusion Criteria: - BMI ranging from 27-42 kg/m2; - Those habitually consuming breakfast (at least 5 times a week). Exclusion Criteria: - women who are pregnant, planning to be pregnant or breastfeeding - subjects with food allergies which prevent consumption of the study diet. - diagnosis of diabetes, hypertension, renal, hepatic, haematological disease, coronary heart disease, metabolic disease, gastrointestinal disease - having given a pint of blood for transfusion purposes within the last month - unsuitable veins for blood sampling - inability to understand the participant information sheet - inability to speak, read and understand the English language - those on any prescription medications (other than oral contraceptives) which will adversely affect the study outcomes (i.e. medications affecting, circadian timing, sleep or metabolic function). - those on any specific diet regimes - those on any weight loss programmes (that may be affecting lifestyle, physical activity and diet). - Extremes of chronotypes, sleep patterns and physical activity. |
Country | Name | City | State |
---|---|---|---|
United Kingdom | The Rowett Institute | Aberdeen |
Lead Sponsor | Collaborator |
---|---|
University of Aberdeen | Maastricht University, University of Surrey |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Energy balance | Change in energy balance during each diet protocol (body weight (kg)) | Measured up to day 71 of study | |
Secondary | Total Daily Energy Expenditure | Total energy expenditure measured by DLW for the 4 week BB and BD diet phases | 4 x 2 weeks. Throughout weeks 2-5 and 7-10. | |
Secondary | Resting Metabolic Rate (RMR) | RMR measured with indirect calorimetry (ventilated hood) | Baseline,week 1, week 5, week 6, week 10. | |
Secondary | Thermic effect of food (TEF) | TEF measured with indirect calorimetry (ventilated hood) for 6 hours after a breakfast meal | Week 1, week 5, week 6, week 10. | |
Secondary | Body Volume | Measured with Air Displacement plethysmography (BODPOD), | Week 1, week 5, week 6, week 10. | |
Secondary | Bone Mineral Content | Measured with Dual energy x-ray absorptiometry (DEXA) | Week 1, week 5, week 6, week 10. | |
Secondary | Total Body Water | Measured with deuterium dilution | Week 1, week 5, week 6, week 10. | |
Secondary | Body Composition | 4 compartment model to assess changes in body composition (Combined from the measures of body weight, body volume, total body water and bone mineral) | Week 1, week 5, week 6, week 10. | |
Secondary | Gastric emptying | Gastric emptying measured using stable isotope, Octanoic acid labelled breath samples. | Week 1, week 5, week 6, week 10. | |
Secondary | Waist and hip circumference | Change in waist and hip circumferences and waist to hip ratio | Week 1, week 5, week 6, week 10. | |
Secondary | Gut appetite hormones | Change in plasma fasting and 2 hr post-meal appetite hormones | Week 1, week 5, week 6, week 10. | |
Secondary | Plasma glucose | Change in plasma fasting and 2 hr post-meal glucose | Week 1, week 5, week 6, week 10. | |
Secondary | Plasma insulin | Change in plasma fasting and 2 hr post-meal insulin | Week 1, week 5, week 6, week 10. | |
Secondary | Blood lipids | Change in plasma fasting and 2 hr post-meal blood lipids | Week 1, week 5, week 6, week 10. | |
Secondary | Daily Subjective Appetite | Changes in subjective appetite (hunger, fullness, desire to eat) measured using visual analogue scale questionnaires every waking hour for 3 days. | Hourly measures for 3 days in week 1,week 5, week 6, week 10. | |
Secondary | Postprandial Subjective Appetite | Changes in subjective appetite (hunger, fullness, desire to eat) measured using visual analogue scale questionnaires every 30 minutes for 6 hours after test meals. | Week 1, week 5, week 6, week 10. | |
Secondary | Faecal sample analysis for gut health | Chronic influence on changes in gut microbiota | Week 1, week 5, week 6, week 10. | |
Secondary | Physical activity | Change in physical activity levels measured with accelerometer (actigraph) | Measured continuously for 24 hours for 3 days in week 1,week 5, week 6, week 10. | |
Secondary | 24 hour blood glucose | Changes in 24 hour blood glucose levels measured with a continuous glucose monitor | Measured continuously for 24 hours for 3 days in week 1,week 5, week 6, week 10. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |